Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs
Molecules · 2024
DOI: 10.3390/molecules29112436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Changlin Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Function Materials and Devices, Soochow University, S…. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanoparticles, Myeloid-Derived Suppressor Cells, Immunotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suzhou Key Laboratory of Nanotechnology and Biomedicine, Collaborative Innovation Center of Suzhou Nano Science & Technology, 111 Project.
Abstract (Originalsprache)
Myeloid-derived suppressor cells (MDSCs) are recognized as major immune suppressor cells in the tumor microenvironment that may inhibit immune checkpoint blockade (ICB) therapy. Here, we developed a Stattic-loaded mesoporous silica nanoparticle (PEG-MSN-Stattic) delivery system to tumor sites to reduce the number of MDSCs in tumors. This approach is able to significantly deplete intratumoral MSDCs and thereby increase the infiltration of T lymphocytes in tumors to enhance ICB therapy. Our approach may provide a drug delivery strategy for regulating the tumor microenvironment and enhancing cancer immunotherapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Function Materials and Devices, Soochow University, Suzhou 215123, China.
ORCID-Profile: Chao Wang
Förderung
- Suzhou Key Laboratory of Nanotechnology and Biomedicine
- Collaborative Innovation Center of Suzhou Nano Science & Technology
- 111 Project
- Joint International Research Laboratory of Carbon-Based Functional Materials and Devices
Zitieren
APA
Xu, C., Amna, N., Shi, Y., Sun, R., Weng, C., Chen, J., Dai, H., & Wang, C. (2024). Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs. Molecules. https://doi.org/10.3390/molecules29112436
Vancouver
Xu C, Amna N, Shi Y, Sun R, Weng C, Chen J, et al. Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs. Molecules. 2024. doi:10.3390/molecules29112436
BibTeX
@article{Xu2024,
author = {Xu, Changlin and Amna, Nida and Shi, Yuchen and Sun, Rong and Weng, Chenhui and Chen, Jiaoyu and Dai, Huaxing and Wang, Chao},
title = {Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29112436}
}
EUVIMED